S&P Futures
4,168.25-8.00(-0.19%)Dow Futures
33,971.00-110.00(-0.32%)Nasdaq Futures
14,033.00+3.50(+0.02%)
KraneShares MSCI All China Health Care Index ETF (KURE)
| Previous Close | 38.58 |
| Open | 38.47 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 1000 |
| Day's Range | 38.34 - 38.89 |
| 52 Week Range | 24.80 - 47.69 |
| Volume | 53,489 |
| Avg. Volume | 145,498 |
| Net Assets | 238.19M |
| NAV | 38.56 |
| PE Ratio (TTM) | N/A |
| Yield | 0.00% |
| YTD Daily Total Return | -0.90% |
| Beta (5Y Monthly) | 0.63 |
| Expense Ratio (net) | 0.65% |
| Inception Date | 2018-01-31 |
- Investopedia
Best Pharmaceutical ETFs for Q2 2021
Pharmaceutical exchange-traded funds (ETFs) offer investors access to a basket of U.S.-based and foreign stocks of drug manufacturers and related companies in a single investment. These companies discover, develop, and produce medications used to cure disease, vaccinate, or alleviate symptoms of illness.
- ETF.com
COVID Impact Varies Across Emerging Market ETFs
Emerging markets have been hit hard by coronavirus, but some were hit harder than others.
- PR Newswire
KraneShares Launches Krane All China Growth Strategy Model
KraneShares, a global asset management firm known for its China-focused exchange-traded funds (ETFs) and innovative China investment strategies, today announced the launch of the Krane All China Growth Strategy. The model seeks to provide investors exposure to the brightest high-growth areas within China's economy. Specifically, the model will include China's rapidly growing internet and healthcare sectors, as well as the exact Mainland China A-Share securities being added into MSCI's Emerging Markets Index, tracked by $1.5 trillion in assets.1
